Literature DB >> 10952979

Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons.

B Vincent1, E Paitel, Y Frobert, S Lehmann, J Grassi, F Checler.   

Abstract

Cellular prion protein (PrP(c)) undergoes a proteolytic attack at the 110/111 downward arrow112 peptide bond, whereas the PrP isoform (PrP(res)) that accumulates in the brain tissue in Creutzfeldt-Jakob disease reveals an alternate cleavage site at about residue 90. Interestingly, the normal processing of PrP occurs inside the 106-126 amino acid region thought to be responsible for the neurotoxicity of the pathogenic prions, whereas PrP(res) cleavage preserves this potentially toxic domain. Therefore, any molecular mechanisms leading to enhanced cleavage at the 110/111 downward arrow112 peptide bond could be of potential interest. We set up TSM1 neurons and HEK293 stable transfectants overexpressing the wild-type or 3F4-tagged murine PrP(c), respectively. Both mock-transfected and PrP(c)-expressing cell lines produced an 11-12-kDa PrP fragment (referred to as N1), the immunological characterization of which strongly suggests that it corresponds to the N-terminal PrP(c) fragment derived from normal processing. We have established that the recovery of secreted N1 is increased by the protein kinase C agonists PDBu and PMA in a time- and dose-dependent manner in both cell lines. In contrast, secretion of N1 remains unaffected by the inactive PDBu analog alphaPDD and by the protein kinase A effectors dibutyryl cAMP and forskolin. Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952979     DOI: 10.1074/jbc.M004628200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Authors:  Shawn Browning; Christopher A Baker; Emery Smith; Sukhvir P Mahal; Maria E Herva; Cheryl A Demczyk; Jiali Li; Charles Weissmann
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1).

Authors:  Frédéric Checler
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

3.  Use of thermolysin in the diagnosis of prion diseases.

Authors:  Jonathan P Owen; Ben C Maddison; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

4.  Effects of FlAsH/tetracysteine (TC) Tag on PrP proteolysis and PrPres formation by TC-scanning.

Authors:  Yuzuru Taguchi; Lindsay A Hohsfield; Jason R Hollister; Gerald S Baron
Journal:  Chembiochem       Date:  2013-08-13       Impact factor: 3.164

5.  The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo.

Authors:  Marie-Victoire Guillot-Sestier; Claire Sunyach; Charlotte Druon; Sabine Scarzello; Frédéric Checler
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

6.  The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

Authors:  Moustapha Cissé; Eric Duplan; Marie-Victoire Guillot-Sestier; Joaquim Rumigny; Charlotte Bauer; Gilles Pagès; Hans-Dieter Orzechowski; Barbara E Slack; Frédéric Checler; Bruno Vincent
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

7.  Separate mechanisms act concurrently to shed and release the prion protein from the cell.

Authors:  Lotta Wik; Mikael Klingeborn; Hanna Willander; Tommy Linne
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

8.  Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells.

Authors:  Katarina M Luhr; Elin K Nordström; Peter Löw; Hans-Gustaf Ljunggren; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 9.  Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND.

Authors:  Bezawit Megra; Eliseo Eugenin; Toni Roberts; Susan Morgello; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-25       Impact factor: 4.147

10.  Unexpected tolerance of alpha-cleavage of the prion protein to sequence variations.

Authors:  José B Oliveira-Martins; Sei-ichi Yusa; Anna Maria Calella; Claire Bridel; Frank Baumann; Paolo Dametto; Adriano Aguzzi
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.